Bulletin of Russian State Medical University, issue (3)2020, pages 49-57

Effects of empagliflozin and L-ornithine L-aspartate on behavior, cognitive functions, and physical performance in mice with experimentally induced steatohepatitis

Publication typeJournal Article
Publication date2020-06-23
Quartile SCImago
Q4
Quartile WOS
Impact factor0.2
ISSN25001094, 25421204
General Medicine
Abstract

Non-alcoholic fatty liver disease (NAFLD) is a chronic condition characterized by disturbed carbohydrate and lipid metabolism and often complicated by psychoneurological symptoms, including anxiety, depression, memory deficit, and asthenia. Most studies of pharmacotherapy candidates for NAFLD focus on the ability of the tested drugs to restore the biochemical functions and morphology of the liver while their potential effects on the co-existing conditions remain overlooked. The aim of this paper was to investigate the effects of empagliflozin and L-ornithine L-aspartate (OA) on behavior, memory, and physical performance in C57BL/6 mice with experimentally induced NAFLD (6 months of a Western diet + weekly carbon tetrachloride injections). The disease affected animal behavior (locomotion speed decreased by 38% and 35%, p < 0.01; rearing increased by 432% and 279%, p < 0.05 etc.), induced long-term memory deficit (latency to find the target box increased by 108% in the Barnes maze, the number of errors increased by 439%, p < 0.05), and compromised physical performance (swimming time in the forced swim test dropped by 50%, p < 0.05 etc.). When administered during the high-calorie diet period, both drugs reduced anxiety (empagliflozin: the number of grooming bouts rose by 160%, p < 0.05 and 2173%, p < 0.01; time spent in the light compartment in the light/dark box test increased by 275%, p < 0.05, etc.; OA: time spent in the open arms of the maze increased by 267%, p < 0.05), and promoted memory retention in mice with NAFLD. OA improved physical performance (swimming time in the forced swimming test improved by 106%, p < 0.05, etc.). Thus, empagliflozin and OA can have a beneficial effect on cognitive functions, as well as behavior, and ameliorate asthenia in NAFLD.

Citations by journals

1
Biomedicines
Biomedicines, 1, 33.33%
Biomedicines
1 publication, 33.33%
Journal Biomed (BIOMEDICINE)
Journal Biomed (BIOMEDICINE), 1, 33.33%
Journal Biomed (BIOMEDICINE)
1 publication, 33.33%
Livers
Livers, 1, 33.33%
Livers
1 publication, 33.33%
1

Citations by publishers

1
2
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 2, 66.67%
Multidisciplinary Digital Publishing Institute (MDPI)
2 publications, 66.67%
Scientific Center for Biomedical Technologies of the Federal Medical-Biological Agency
Scientific Center for Biomedical Technologies of the Federal Medical-Biological Agency, 1, 33.33%
Scientific Center for Biomedical Technologies of the Federal Medical-Biological Agency
1 publication, 33.33%
1
2
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Prikhodko V. A. et al. Effects of empagliflozin and L-ornithine L-aspartate on behavior, cognitive functions, and physical performance in mice with experimentally induced steatohepatitis // Bulletin of Russian State Medical University. 2020. Vol. (3)2020. pp. 49-57.
GOST all authors (up to 50) Copy
Prikhodko V. A., Sysoev Y., Poveryaeva M., Bunyat A., Karev V., Ivkin D., Sukhanov D., Shustov E., Okovityi S. Effects of empagliflozin and L-ornithine L-aspartate on behavior, cognitive functions, and physical performance in mice with experimentally induced steatohepatitis // Bulletin of Russian State Medical University. 2020. Vol. (3)2020. pp. 49-57.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.24075/brsmu.2020.034
UR - https://doi.org/10.24075%2Fbrsmu.2020.034
TI - Effects of empagliflozin and L-ornithine L-aspartate on behavior, cognitive functions, and physical performance in mice with experimentally induced steatohepatitis
T2 - Bulletin of Russian State Medical University
AU - Prikhodko, Veronika A.
AU - Sysoev, YuI
AU - Poveryaeva, MA
AU - Bunyat, AV
AU - Karev, VE
AU - Ivkin, DYu
AU - Sukhanov, DS
AU - Shustov, EB
AU - Okovityi, SV
PY - 2020
DA - 2020/06/23 00:00:00
PB - Pirogov Russian National Research Medical University
SP - 49-57
IS - (3)2020
SN - 2500-1094
SN - 2542-1204
ER -
BibTex
Cite this
BibTex Copy
@article{2020_Prikhodko,
author = {Veronika A. Prikhodko and YuI Sysoev and MA Poveryaeva and AV Bunyat and VE Karev and DYu Ivkin and DS Sukhanov and EB Shustov and SV Okovityi},
title = {Effects of empagliflozin and L-ornithine L-aspartate on behavior, cognitive functions, and physical performance in mice with experimentally induced steatohepatitis},
journal = {Bulletin of Russian State Medical University},
year = {2020},
publisher = {Pirogov Russian National Research Medical University},
month = {jun},
url = {https://doi.org/10.24075%2Fbrsmu.2020.034},
number = {(3)2020},
pages = {49--57},
doi = {10.24075/brsmu.2020.034}
}
Found error?